cystine/悪性腫瘍

It is a purpose of this invention to create a cytostatic composition for treatment of transplanted tumors in animals by structurally combining antimetabolics (the hydrazide of cystine and of cysteine, respectively) with an alkylating group. In connection with the invention, U.S. Pat. No. 3,897,494,

SUMMARY OF INVENTION The inventors propose a combination of an HMG-CoA reductase inhibitor (also referred to as "HMG-CoA inhibitor(s)"), and COX-2 inhibitor for the treatment of cancer especially prostate cancer and a method of treatment of cancer by that combination, especially prostate cancer. The

BACKGROUND OF THE INVENTION Apoptosis, or programmed cell death, is a naturally occurring process that has been strongly conserved during evolution to prevent uncontrolled cell proliferation. This form of cell suicide plays a critical role in ensuring the development and maintenance of multicellular

BACKGROUND OF THE INVENTION Transferrin is a protein found in the blood of all humans and its known function is to carry iron to those organs and cells of the body that require this metal for normal function. Recently, scientists have reported that an important function of iron carried by

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the fields of medicine and biology. More particularly, it concerns compositions and methods for the treatment of cancer with enzymes that deplete both L-cystine and L-cysteine. Even more particularly, it

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the fields of medicine and biology. More particularly, it concerns compositions and methods for the treatment of cancer with enzymes that deplete both L-cystine and L-cysteine. Even more particularly, it

REFERENCE TO SEQUENCE LISTING, COMPUTER PROGRAM, OR COMPACT DISK In accordance with "Legal Framework for EFS-Web," (2006 Apr. 11) submit herewith is a sequence listing as an ASCII text file. The text file will serve as both the paper copy required by 37 CFR 1.821(c) and the computer readable form

FIELD OF THE INVENTION The invention relates to compositions and methods for the targeted delivery of therapeutic and diagnostic agents, including targeted intracellular delivery therapeutic and diagnostic agents, and to the treatment of hyperproliferative diseases. BACKGROUND The effectiveness of

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a protein, named ACA1, purified from Antrodia camphorata, and more particularly to the amino acid sequence of ACA1 and its immunomodulatory activity, as demonstrated by its stimulatory activity toward RAW 264.7

FIELD OF THE DISCLOSURE The present disclosure relates generally to the treatment and or prevention of a diseases state that required cystine for maintenance of progression of the disease state. More specifically, the present disclosure relates to the treatment and prevention of glioma via the

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a new antitumor substance and, in particular, relates to a new substance having antitumor activity against certain types of tumors and containing protein, which substance is obtained from an epidermal portion of rice. 2.